418 related articles for article (PubMed ID: 28049728)
21. Familial Alzheimer's disease mutations differentially alter amyloid β-protein oligomerization.
Gessel MM; Bernstein S; Kemper M; Teplow DB; Bowers MT
ACS Chem Neurosci; 2012 Nov; 3(11):909-18. PubMed ID: 23173071
[TBL] [Abstract][Full Text] [Related]
22. The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.
Benilova I; Gallardo R; Ungureanu AA; Castillo Cano V; Snellinx A; Ramakers M; Bartic C; Rousseau F; Schymkowitz J; De Strooper B
J Biol Chem; 2014 Nov; 289(45):30977-89. PubMed ID: 25253695
[TBL] [Abstract][Full Text] [Related]
23. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
24. Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM.
Norlin N; Hellberg M; Filippov A; Sousa AA; Gröbner G; Leapman RD; Almqvist N; Antzutkin ON
J Struct Biol; 2012 Oct; 180(1):174-89. PubMed ID: 22750418
[TBL] [Abstract][Full Text] [Related]
25. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
[TBL] [Abstract][Full Text] [Related]
26. Conformational Characterization of Native and L17A/F19A-Substituted Dutch-Type β-Amyloid Peptides.
He KC; Chen YR; Liang CT; Huang SJ; Tzeng CY; Chang CF; Huang SJ; Huang HB; Lin TH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272787
[TBL] [Abstract][Full Text] [Related]
27. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
28. Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1).
Tanemura K; Chui DH; Fukuda T; Murayama M; Park JM; Akagi T; Tatebayashi Y; Miyasaka T; Kimura T; Hashikawa T; Nakano Y; Kudo T; Takeda M; Takashima A
J Biol Chem; 2006 Feb; 281(8):5037-41. PubMed ID: 16377636
[TBL] [Abstract][Full Text] [Related]
29. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
30. Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant.
Levy E; Prelli F; Frangione B
J Alzheimers Dis; 2006; 9(3 Suppl):329-39. PubMed ID: 16914871
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
32. FAD-linked mutations in presenilin 1 alter the length of Abeta peptides derived from betaAPP transmembrane domain mutants.
Murphy MP; Uljon SN; Golde TE; Wang R
Biochim Biophys Acta; 2002 Mar; 1586(2):199-209. PubMed ID: 11959461
[TBL] [Abstract][Full Text] [Related]
33. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
[TBL] [Abstract][Full Text] [Related]
34. Genetic aspects of amyloid beta-protein fibrillogenesis in Alzheimer's disease.
Kowalska A
Folia Neuropathol; 2004; 42(4):235-7. PubMed ID: 15679042
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
[TBL] [Abstract][Full Text] [Related]
36. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
[TBL] [Abstract][Full Text] [Related]
37. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.
Maisam M; Khan MT; Lodhi MS; Mou K; Liu Z; Wei D
Front Biosci (Landmark Ed); 2023 Oct; 28(10):258. PubMed ID: 37919079
[TBL] [Abstract][Full Text] [Related]
39. Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.
Hubin E; Deroo S; Schierle GK; Kaminski C; Serpell L; Subramaniam V; van Nuland N; Broersen K; Raussens V; Sarroukh R
Cell Mol Life Sci; 2015 Dec; 72(24):4899-913. PubMed ID: 26190022
[TBL] [Abstract][Full Text] [Related]
40. Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.
Shimada H; Minatani S; Takeuchi J; Takeda A; Kawabe J; Wada Y; Mawatari A; Watanabe Y; Shimada H; Higuchi M; Suhara T; Tomiyama T; Itoh Y
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
